Publication | Open Access

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Breast OncologyMedicineImmunologyPathologyCancer GenomicsImmunogenomic ProfilingImmune Checkpoint InhibitorBreast CancerTriple-negative Breast CancerOncologyTumor MicroenvironmentTumor BiologyPathological Response Results